Veterinary Medicines

Nafpenzal T

Authorised
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine monohydrate
  • Nafcillin sodium monohydrate
Download as PDF

Product identification

Medicine name:
Nafpenzal T
Active substance:
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine monohydrate
  • Nafcillin sodium monohydrate
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Dihydrostreptomycin sulfate
    134.23
    milligram(s)
    /
    3.00
    gram(s)
  • Benzylpenicillin procaine monohydrate
    300.00
    milligram(s)
    /
    3.00
    gram(s)
  • Nafcillin sodium monohydrate
    121.95
    milligram(s)
    /
    3.00
    gram(s)
Pharmaceutical form:
  • Ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Milk
        5
        day
      • Meat and offal
        17
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC22
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6830405.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 24/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."